Cite
Pharmacogenomics implementation in cardiovascular disease in a highly diverse population: initial findings and lessons learned from a pilot study in United Arab Emirates.
MLA
Al-Mahayri, Zeina N., et al. “Pharmacogenomics Implementation in Cardiovascular Disease in a Highly Diverse Population: Initial Findings and Lessons Learned from a Pilot Study in United Arab Emirates.” Human Genomics, vol. 16, no. 1, Sept. 2022, p. 42. EBSCOhost, https://doi.org/10.1186/s40246-022-00417-9.
APA
Al-Mahayri, Z. N., Khasawneh, L. Q., Alqasrawi, M. N., Altoum, S. M., Jamil, G., Badawi, S., Hamza, D., George, L., AlZaabi, A., Ouda, H., Al-Maskari, F., AlKaabi, J., Patrinos, G. P., & Ali, B. R. (2022). Pharmacogenomics implementation in cardiovascular disease in a highly diverse population: initial findings and lessons learned from a pilot study in United Arab Emirates. Human Genomics, 16(1), 42. https://doi.org/10.1186/s40246-022-00417-9
Chicago
Al-Mahayri, Zeina N, Lubna Q Khasawneh, Mais N Alqasrawi, Sahar M Altoum, Gohar Jamil, Sally Badawi, Dana Hamza, et al. 2022. “Pharmacogenomics Implementation in Cardiovascular Disease in a Highly Diverse Population: Initial Findings and Lessons Learned from a Pilot Study in United Arab Emirates.” Human Genomics 16 (1): 42. doi:10.1186/s40246-022-00417-9.